Cancer Breakthrough: Common Drug Effectively Reduces Aggressive Brain Tumours
Cancer Breakthrough Using Common Drug
A CHEAP drug that’s already on the market could be effective against deadly brain tumours, scientists say. Glioblastomas are aggressive and fast-growing brain tumours affecting around 3,200 individuals in the UK annually. Researchers have found that this common medication not only targets the cancer effectively but does so with minimal side effects.
How the Drug Works
- Mechanism of Action: The drug works by inhibiting specific pathways critical to glioblastoma cell survival.
- Market Availability: Currently available through the NHS, ensuring accessibility for patients.
Implications for Treatment Protocols
This discovery could shift treatment paradigms for glioblastoma management. By integrating this drug into existing treatment protocols, healthcare providers might improve outcomes for patients facing this daunting diagnosis.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.